Expanding Diagnostic Platform LightDeck Diagnostics has developed a versatile, lab-quality portable diagnostic platform that delivers rapid results within minutes, with proven application in veterinary, environmental, and human healthcare markets. This technology’s ability to perform multiplex tests simultaneously offers opportunities to offer comprehensive testing panels to healthcare providers, veterinary clinics, and environmental testing labs.

Strategic Acquisitions Following Heska Corporation's acquisition in January 2023 and the merger with Brava Diagnostics in 2020, LightDeck is positioned to leverage its expanded manufacturing and technical capabilities. These developments create opportunities for partnerships or sales channels to broader markets such as veterinary diagnostics and infectious disease detection.

Focus on Infectious Disease Testing With ongoing development of COVID-19 and other infectious disease panels, LightDeck offers a compelling solution for healthcare providers and public health agencies seeking rapid, accurate, point-of-care testing with internal quality controls. There is a significant market demand for streamlined testing for COVID-19, sepsis, and other pathogens in both clinical and emergency settings.

Potential Public-Private Collaborations Previous collaborations with BARDA, DARPA, and SRI indicate a strong interest in innovative diagnostics for critical health and homeland security applications. Opportunities exist for government agencies, military healthcare, and emergency response units to adopt LightDeck’s platform for rapid, field-deployable testing solutions.

Emerging Market Demand With a revenue range of 10 to 25 million and a focus on low-cost, simple, and quantitative testing, LightDeck is well-positioned to capture increased demand across healthcare, veterinary, and environmental markets. Business development efforts targeting regional labs, health systems, and veterinary networks could capitalize on this growth trajectory.